Critical Insight on How HIV Evades The Immune System

by Bidita Debnath on  April 19, 2016 at 2:02 AM AIDS/HIV News
RSS Email Print This Page Comment
Font : A-A+

Immune checkpoints are immunological "brakes" that prevent the over-activation of the immune system on healthy cells. Scientists have identified a human (host) protein that weakens the immune response to HIV and other viruses.
 Critical Insight on How HIV Evades The Immune System
Critical Insight on How HIV Evades The Immune System

"Our study provides critical insight on a paramount issue in HIV research: Why is the body unable to mount an efficient immune response to HIV to prevent transmission?" said one of the researchers Sumit Chanda, professor and director of Sanford Burnham Prebys Medical Discovery Institute (SBP) in the US.

The findings showed that a deficiency in NLRX1 -- an intracellular protein -- reduces the replication of the HIV virus. It also slows down the power of immune system and promotes immunity to infection.

"Importantly, we were able to show that deficiencies in NLRX1 reduce HIV replication, suggesting that the development of small molecules to modulate the innate immune response may inhibit viral transmission and promote immunity to infection," Chanda added, in the paper published in the journal Cell Host and Microbe.

Further, host immune checkpoints that control the immune response to cancer were also discovered. "This research expands our understanding of the role of host proteins in viral replication and the innate immune response to HIV infection, and can be extended to DNA viruses such as HSV and vaccinia," added another researcher Haitao Guo, postdoctoral research associate at University of North Carolina.

Immune checkpoints are immunological "brakes" that prevent the over-activation of the immune system on healthy cells. Tumour cells often take advantage of these checkpoints to escape detection of the immune system. The results have important implications for improving HIV antiviral therapies, creating effective viral vaccines, and advance a new approach to treat cancer, the team concluded.

Source: IANS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Oral Health And AIDS AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs Prostitution: Fresh Stakes in the Oldest Trade HIV Symptom 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive